ATAGÜNDÜZ, I. Et Al. 2017. Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.2 , 120-125.

ATAGÜNDÜZ, I., TOPTAŞ, T., Deniz, R., Kara, O., Eser, A., Sezgin, A., ... Ozgumus, T.(2017). Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.2, 120-125.

ATAGÜNDÜZ, IŞIK Et Al. "Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.2, 120-125, 2017

ATAGÜNDÜZ, IŞIK Et Al. "Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.2, pp.120-125, 2017

ATAGÜNDÜZ, I. Et Al. (2017) . "Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.2, pp.120-125.

@article{article, author={IŞIK ATAGÜNDÜZ Et Al. }, title={Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2017, pages={120-125} }